Literature DB >> 10862597

Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.

Y Hojo1, U Ikeda, T Katsuki, O Mizuno, H Fukazawa, K Kurosaki, H Fujikawa, K Shimada.   

Abstract

OBJECTIVE: To investigate changes in cytokine expression in the coronary circulation induced by percutaneous transluminal coronary angioplasty (PTCA).
METHODS: The study involved 32 patients with ischaemic heart disease who underwent elective PTCA for isolated stenotic lesions of the left coronary artery. Ten patients had plain old balloon angioplasty, 10 had percutaneous transluminal rotational atherectomy, and 12 had stent implantation. Blood samples were drawn from the coronary sinus before and immediately after PTCA. Plasma concentrations of interleukin 6 (IL-6), platelet derived growth factor (PDGF), monocyte chemoattractant protein 1 (MCP-1), and macrophage coronary stimulating factor (M-CSF) were measured. The patients were scheduled for follow up angiography six months after PTCA. Late loss index was calculated using quantitative coronary angiography.
RESULTS: IL-6 concentrations in coronary sinus blood increased immediately after PTCA (p < 0.001), but there was no change in PDGF, MCP-1, or M-CSF. There was a positive correlation between changes in IL-6 concentrations immediately after PTCA and late loss index six months after PTCA (r = 0.73, p < 0.001). IL-6 concentrations in coronary sinus blood were higher in patients with late restenosis than in those without restenosis (p < 0.001).
CONCLUSIONS: PTCA induces IL-6 production in the coronary circulation. This may induce subsequent inflammatory responses in injured vessels and play an important role in late restenosis after PTCA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862597      PMCID: PMC1729404          DOI: 10.1136/heart.84.1.83

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  25 in total

1.  Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells.

Authors:  M Mitsumata; R S Fishel; R M Nerem; R W Alexander; B C Berk
Journal:  Am J Physiol       Date:  1993-07

2.  Cardiac release of cytokines and inflammatory responses in acute myocardial infarction.

Authors:  F J Neumann; I Ott; M Gawaz; G Richardt; H Holzapfel; M Jochum; A Schömig
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

3.  T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty.

Authors:  A Blum; S Sclarovsky; B Shohat
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

4.  In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.

Authors:  J C Mestries; E K Kruithof; M P Gascon; F Herodin; D Agay; A Ythier
Journal:  Eur Cytokine Netw       Date:  1994 May-Jun       Impact factor: 2.737

5.  Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.

Authors:  G L Kukielka; C W Smith; G J LaRosa; A M Manning; L H Mendoza; T J Daly; B J Hughes; K A Youker; H K Hawkins; L H Michael; A Rot; M L Entman
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Fibrinogen after coronary angioplasty as a risk factor for restenosis.

Authors:  G Montalescot; A Ankri; E Vicaut; G Drobinski; Y Grosgogeat; D Thomas
Journal:  Circulation       Date:  1995-07-01       Impact factor: 29.690

7.  Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions.

Authors:  Y Seino; U Ikeda; M Ikeda; K Yamamoto; Y Misawa; T Hasegawa; S Kano; K Shimada
Journal:  Cytokine       Date:  1994-01       Impact factor: 3.861

8.  Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells.

Authors:  E L Filonzi; H Zoellner; H Stanton; J A Hamilton
Journal:  Atherosclerosis       Date:  1993-03       Impact factor: 5.162

9.  Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment.

Authors:  A Pietersma; M Kofflard; L E de Wit; T Stijnen; J F Koster; P W Serruys; W Sluiter
Journal:  Circulation       Date:  1995-03-01       Impact factor: 29.690

10.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  16 in total

1.  Time course of transcardiac interleukin-6 release after coronary stenting for stable angina.

Authors:  J M Kefer; L M Galanti; C E Hanet
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

Review 2.  The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

Authors:  Thierry Charron; Nafiseh Nili; Bradley H Strauss
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

3.  Effects of preinjury administration of corticosteroids on pseudointimal hyperplasia and cytokine response in a rat model of balloon aortic injury.

Authors:  Kazuhito Nagasaki; Kenji Matsumoto; Munehisa Kaneda; Tsunehiro Shintani; Shintaro Shibutani; Takaya Murayama; Go Wakabayashi; Motohide Shimazu; Makio Mukai; Masaki Kitajima
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

Review 4.  Impact of C-reactive protein on in-stent restenosis: a meta-analysis.

Authors:  Jian-Jun Li; Yi Ren; Ke-Ji Chen; Alan C Yeung; Bo Xu; Xin-Min Ruan; Yue-Jin Yang; Ji-Lin Chen; Run-Lin Gao
Journal:  Tex Heart Inst J       Date:  2010

5.  Cardiac release and kinetics of cytokines after elective bare metal coronary stenting.

Authors:  NourEddine ElMokhtari; Sascha Zschernitz; Susanne Sebens; Gunhild Simon-Herrmann; Dietmar Krüger
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

6.  Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention.

Authors:  Gaurav K Gupta; Kajari Dhar; Michael G Del Core; William J Hunter; Georgios I Hatzoudis; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2011-04-22       Impact factor: 3.362

7.  Azithromycin does not prevent six-month myointimal proliferation but attenuates the transient systemic inflammation occurring after coronary stenting.

Authors:  Dimas T Ikeoka; Carolina Z Vieira; Pedro A Lemos; Tania V Strabelli; Expedito E Ribeiro da Silva; Marco A Perin; Andrea Groselj-Strele; Beate Tiran; Andreas Tiran; Bruno Caramelli
Journal:  Clin Res Cardiol       Date:  2008-10-13       Impact factor: 5.460

Review 8.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

9.  Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries.

Authors:  Taku Matsubara; Takaharu Ishibashi; Tomoyuki Hori; Kazuyuki Ozaki; Tohru Mezaki; Keiichi Tsuchida; Akimitsu Nasuno; Kaname Kubota; Takayuki Tanaka; Takashi Miida; Yoshifusa Aizawa; Matomo Nishio
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

10.  Effect of the intravascular low energy laser illumination during percutaneous coronary intervention on the inflammatory process in vascular wall.

Authors:  Arkadiusz Derkacz; Marcin Protasiewicz; Rafał Poręba; Adrian Doroszko; Ryszard Andrzejak
Journal:  Lasers Med Sci       Date:  2012-06-26       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.